Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy – a retrospective analysis

Sequencing chemotherapy and radiotherapy in locoregional advanced breast cancer patients after mastectomy – a retrospective analysis

<p>Abstract</p> <p>Background</p> <p>Combined chemo- and radiotherapy are established in breast cancer treatment. Chemotherapy is recommended prior to radiotherapy but decisive data on the optimal sequence are rare. This retrospective analysis aimed to assess the role o...

Full description

Bibliographic Details
Main Authors:	Stanzel Sven, Gagel Bernd, Pinkawa Michael, Piroth Marc D, Asadpour Branka, Eble Michael J
Format:	Article
Language:	English
Published:	BMC 2008-04-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/8/114

Similar Items

Sequential (gemcitabine/vinorelbine) and concurrent (gemcitabine) radiochemotherapy with FDG-PET-based target volume definition in locally advanced non-small cell lung cancer: first results of a phase I/II study
by: Stanzel Sven, et al.
Published: (2007-06-01)

[<sup>18</sup>F] fluoromisonidazole and [<sup>18</sup>F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study
by: Asadpour Branka, et al.
Published: (2006-03-01)

Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment
by: Pinkawa Michael, et al.
Published: (2009-08-01)

Locoregional recurrence patterns in women with breast cancer who have not undergone post-mastectomy radiotherapy
by: Xuran Zhao, et al.
Published: (2020-09-01)

Results of Treatment of Locoregionally Advanced Head and Neck Cancer by Radiotherapy with or without Chemotherapy
by: Mahnaz Roayaei, et al.
Published: (2013-01-01)

Postmastectomy radiotherapy reduces locoregional and disease recurrence in patients with stage II–III triple-negative breast cancer treated with neoadjuvant chemotherapy and mastectomy
by: Chen XX, et al.
Published: (2018-04-01)

pO polarography, contrast enhanced color duplex sonography (CDS), [<sup>18</sup>F] fluoromisonidazole and [<sup>18</sup>F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?
by: Hamacher Kurt, et al.
Published: (2007-06-01)

Recent Advances in Definitive Radiotherapy for Prostate Cancer
by: Michael Pinkawa
Published: (2015-03-01)

Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled study
by: Wen-Ze Qiu, et al.
Published: (2016-01-01)

Induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma
by: Wen-Fei Li, et al.
Published: (2016-11-01)

Induction chemotherapy followed by radiotherapy concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma
by: Li-Ting Liu, et al.
Published: (2020-06-01)

Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study
by: Schaar Sandra, et al.
Published: (2010-04-01)

Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer - predictive factors on irritative symptoms, incontinence and rectal bleeding
by: Klotz Jens, et al.
Published: (2009-09-01)

Factors Predicting Locoregional Recurrence After Neoadjuvant Chemotherapy and Nipple-Sparing/Skin-Sparing Mastectomy With Immediate Breast Reconstruction
by: Zhen-Yu Wu, et al.
Published: (2021-07-01)

Changes in pulmonary function tests in breast carcinoma patients treated with locoregional post-mastectomy radiotherapy: results of a pilot study
by: AlSaeed EF, et al.
Published: (2017-05-01)

Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy
by: Pinkawa Michael, et al.
Published: (2012-12-01)

The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer
by: Ryu Jun, et al.
Published: (2010-08-01)

An Eighteen-Gene Classifier Predicts Locoregional Recurrence in Post-Mastectomy Breast Cancer Patients
by: Skye H. Cheng, et al.
Published: (2016-03-01)

Impact of Postmastectomy Radiotherapy on Locoregional Control and Disease-Free Survival in Patients with Breast Cancer Treated with Neoadjuvant Chemotherapy
by: Yanyu Zhang, et al.
Published: (2021-01-01)

Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?
by: Stefano Guadagni, et al.
Published: (2017-11-01)

Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma
by: Li-Ting Liu, et al.
Published: (2019-10-01)

Comparing Long-Term Survival and Late Toxicities of Different Sequential Chemotherapy Regimens with Intensity-Modulated Radiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Mingyao Wu, et al.
Published: (2020-07-01)

Effectiveness and cost-effectiveness analysis of nimotuzumab for the radiotherapy of locoregionally advanced nasopharyngeal carcinoma
by: Zhaodong Fei, et al.
Published: (2020-10-01)

Interdisciplinary consensus statement on indication and application of a hydrogel spacer for prostate radiotherapy based on experience in more than 250 patients
by: Müller Arndt-Christian, et al.
Published: (2016-09-01)

Outcomes of Induction Chemotherapy Plus Intensity-Modulated Radiotherapy (IMRT) Versus IMRT Plus Concurrent Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched Study
by: Pu-Yun OuYang, et al.
Published: (2016-08-01)

Locoregional Recurrence Risk in Breast Cancer Patients with Estrogen Receptor Positive Tumors and Residual Nodal Disease following Neoadjuvant Chemotherapy and Mastectomy without Radiation Therapy
by: Shravan Kandula, et al.
Published: (2015-01-01)

Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?
by: Eunjin Jwa, et al.
Published: (2015-01-01)

Stage-specific concurrent chemoradiotherapy with or without induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective, population-based study
by: Xia WX, et al.
Published: (2019-11-01)

Cisplatin and Fluorouracil Induction Chemotherapy With or Without Docetaxel in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Ting Jin, et al.
Published: (2019-04-01)

Clinical Observation of Concurrent Radio-Chemotherapy Combined with Adjuvant Chemotherapy in Treating Locoregionally Advanced Nasopharyngeal Carcinoma
by: Yan-ping CHEN, Yun-cong LIU, et al.
Published: (2010-02-01)

Comparison of Locoregional Recurrence with Mastectomy vs. Breast Conserving Surgery in Pregnancy Associated Breast Cancer (PABC)
by: Paniti Sukumvanich, et al.
Published: (2009-12-01)

Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
by: Zhai RP, et al.
Published: (2015-11-01)

Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis
by: Guo-Ying Liu, et al.
Published: (2018-05-01)

Data on distant metastasis and survival after locoregional recurrence following nipple-sparing mastectomy and immediate breast reconstruction
by: Zhen-Yu Wu, et al.
Published: (2021-04-01)

Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis
by: He Y, et al.
Published: (2018-06-01)

Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma 
by: Fayette J, et al.
Published: (2015-11-01)

Treatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience
by: Fangzheng Wang, et al.
Published: (2018-02-01)

Radiation-induced acute injury of intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy in induction chemotherapy followed by concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a prospective cohort study
by: Zexin Yao, et al.
Published: (2021-04-01)

The Clinical Outcomes and Toxicities of Induction Chemotherapy Followed by Concurrent Chemoradiotherapy Plus Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
by: Rui Zou, et al.
Published: (2021-02-01)

Survival benefit of adding chemotherapy to intensity modulated radiation in patients with locoregionally advanced nasopharyngeal carcinoma.
by: Xuemei Ji, et al.
Published: (2013-01-01)